J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology, 1974; 14:339-344
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, D.
Right arrow Articles by Gibaldi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, D.
Right arrow Articles by Gibaldi, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Hypothesis for the Rapid Attainment and Maintenance of Lidocaine Plasma Levels

Daniel Shen B.S.1 and Milo Gibaldi Ph.D.1

1 Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, Buffalo, N.Y. 14214.

The frequent occurrence of life-threatening arrhythmias in the early phase of acute myocardial infarction requires that therapeutic blood levels of an effective antiarrhythmic agent such as lidocaine be established as early as possible. The usual practice of administering an intravenous bolus injection followed by constant-rate infusion of lidocaine can easily lead to either toxic or subtherapeutic blood levels depending on the size of the bolus dose. Based on clinical data and theoretical considerations, it is shown that an essentially constant effective blood level of the drug may be achieved in less than 5 minutes if an appropriate loading dose is given as an intramuscular injection concomitant with a constant-rate intravenous infusion.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
D. J. Greenblatt, D. M. Benjamin, C. R. Willis, J. S. Harmatz, and M. A. Zinny
Lidocaine Plasma Concentrations Following Administration of Intraoral Lidocaine Solution
Arch Otolaryngol Head Neck Surg, May 1, 1985; 111(5): 298 - 300.
[Abstract] [PDF]


Home page
JAMAHome page
D. J. Greenblatt, V. Bolognini, J. Koch-Weser, and J. S. Harmatz
Pharmacokinetic Approach to the Clinical Use of Lidocaine Intravenously
JAMA, July 19, 1976; 236(3): 273 - 277.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Clinical Pharmacology